PharmaLegacy Laboratories is a preclinical Contract Research Organization (CRO) providing specialty pharmacology services in Oncology, Bone, Inflammation, Immune Diseases, and Orthopaedics in Tissue Repairs and Tissue Engineering. The core business of PharmaLegacy stems from our pioneering work and unique knowledge in developing and running specialized animal models to test drug candidates and medical devices for their pharmacological effects and biocompatible repairs, along with the adjacency studies of in vitro biology and PK/PD.
Backed by a US private equity investment, PharmaLegacy is strategically located in the heart of the Biotech and Pharmaceutical Base of Zhangjiang High Tech Industrial Park, Shanghai. We have a 45,000 square-ft facility with SPF labs. Our facility can house > 10,000 rodents and non-rodent animals.
澎立生物医药技术（上海）有限公司是一家临床前合约研究机构，致力于提供肿瘤学、骨骼、炎症、免疫性疾病领域的专业服务、以及与组织修复与组织工程相关的骨外科医疗服务。澎立生物医药的核心业务立足于公司的创新工作和独有的专业技能，研发服务涵盖专用动物模型的开发与运用、试用药物与医疗器械的药理效用和生物相容性测试、以及体外生物学与药代动力学(PK)和药效动力学(PD)的关联研究等。
澎立生物医药技术（上海）有限公司由美国投资，位于中国的生物产业‘硅谷’-上海张江高科技园区生物制药基地的中心区域。公司拥有占地45,000平方英尺的研发中心 ，其中包括大型SPF实验室和能容纳超过1万只啮齿类及非啮齿类动物的动物房。
